Australia-listed Super Retail Group has agreed to buy 100% of Macpac, a New Zealand-headquartered outdoor apparel and equipment supplier owned by CHAMP Ventures, for NZ$144 million ($107 million).
IFM Investors has moved from fund-of-funds through co-investment to a direct approach designed to meet its superannuation fund clients’ concerns about access, cost, and transparency. Is it working?
Should the next-generation Australian private equity firm be doing more to differentiate itself from the competition - in the eyes of potential investees as well as investors?
Two pieces of legislation – one enacted and the other pending – are expected to facilitate corporate restructuring in Australia. It remains to be seen how turnaround investors take advantage of this
Pacific Equity Partners (PEP) has launched an Australia and New Zealand-focused secured assets fund intended to invest in companies that generate annuity income but also offer opportunities for traditional private equity-style operational improvement.
Tim Sims, co-founder and managing director of Pacific Equity Partners, discusses competition in Australian private equity, approaches to co-investment, succession planning, and his firm’s secured assets fund
Private equity is taking a bigger piece of New Zealand’s small economic pie. Investors must act opportunistically to exploit substantial potential in an inconspicuous but engaging middle market
Demographic shifts are prompting Australian GPs to reevaluate domestic consumer plays with an eye toward processes rather than goods. Overseas markets are an increasingly important part of the equation
Nintex, a workflow management software provider founded in Australia but now with a global footprint, has agreed to sell a majority stake to US-based middle market GP Thoma Bravo.
NAB Ventures, a unit of National Australia Bank (NAB), has invested A$5.9 million ($4.6 million) in ActivePipe, a Melbourne-based software supplier for the real estate industry.
Allergan, a US-listed pharmaceutical company and the owner of Botox cosmetic injectable products, has agreed to acquire Elastagen, an Australian skin treatment developer backed by a number of VCs, in a deal worth up to $260 million.
A group of VCs including Tokyo-headquartered East Ventures has completed an $8.5 million Series A round for New Zealand big data computing company Nyriad.
Pacific Equity Partners (PEP) has agreed to buy listed Australian medical devices manufacturer LifeHealthcare for an enterprise valuation of approximately A$211 million ($166 million).
One Tree Agriculture, an Australia-based agriculture investor owned by Proterra Investment Partners, has purchased three farm properties in New South Wales.
The Blackstone Group has offered to buy the panel repair business of Australia-listed automotive aftercare services and accessories provider AMA Group for an enterprise valuation of A$530 million ($427 million).
Permira's first Australia investment provides EQT Partners with an exit from medical imaging service I-Med Radiology Network
Permira is set to make its first investment in Australia after reaching an agreement with EQT Partners to acquire I-Med Radiology Network.
Leveraging a relationship established through an investment in VIP Petfoods, Quadrant Private Equity secured a buyout of Australian candy maker Darrell Lea
BGH Capital, the Australia and New Zealand-focused private equity firm set up by Ben Gray, formerly co-head of TPG Capital in Asia, has set a hard cap of A$2.5 billion ($2 billion) for its debut fund.
Crescent Capital Partners has acquired Australia-based clinical research organization (CRO) Nucleus Network from The Baker Institute, an independent research institute that focuses on heart disease and diabetes.
Despite their strong growth potential, Australian food crops have attracted little activity from the private equity community. Investors’ interest is restrained by the high hurdles to managing these assets
Space technology is being democratized outside its historical geographic and institutional spheres of development. As private investors get on board, a new range of risks and rewards is coming into focus
Quadrant Private Equity has acquired Darrell Lea, a candy maker based in Australia and New Zealand.
Partners Group has sold its entire 21% stake in Australia’s Victorian Comprehensive Cancer Centre (VCCC) to AMP Capital.